Immunic AG | WebDisclosure

Basculer en Français

9803	Companies
196616	Keywords
127635	Articles
104537	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 09/25/2025 at 12:30, 4 months 9 days ago

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
Immunic presented key Vidofludimus Calcium data at the 41st Congress of ECTRIMS, highlighting its potential in multiple sclerosis. The data underscore its neuroprotective potential and promise to slow disease progression

Multiple Sclerosis Immunic Vidofludimus Calcium ECTRIMS Congress Neuroprotective Potential
BRIEF

published on 09/09/2025 at 12:35, 4 months 25 days ago

Immunic obtient un brevet américain pour le vidofludimus calcique dans le traitement de la sclérose en plaques

Sclérose En Plaques Essai De Phase 2 Immunique Vidofludimus Calcique Allocation De Brevet
BRIEF

published on 09/09/2025 at 12:35, 4 months 25 days ago

Immunic Secures U.S. Patent for Vidofludimus Calcium in Multiple Sclerosis

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 Trial Patent Allowance
PRESS RELEASE

published on 09/09/2025 at 12:30, 4 months 25 days ago

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic receives United States Patent Notice of Allowance for Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis, extending protection into 2041

United States Patent Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Patent Notice Of Allowance
BRIEF

published on 09/04/2025 at 12:35, 5 months ago

Immunic Announces Participation in Key Conferences

Immunic Vidofludimus Calcium Investor Meetings Biopharma Conference ECTRIMS 2025
BRIEF

published on 09/04/2025 at 12:35, 5 months ago

Immunic annonce sa participation à des conférences clés

Réunions D'investisseurs Immunique Vidofludimus Calcique ECTRIMS 2025 Conférence Biopharmaceutique
PRESS RELEASE

published on 09/04/2025 at 12:30, 5 months ago

Immunic to Participate in Investor and Scientific Conferences in September
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in September, including H.C. Wainwright 27th Annual Global Investment Conference and ECTRIMS Congress

Investor Conference Clinical Pipeline Scientific Conference Immunic Inc ECTRIMS Congress
BRIEF

published on 08/07/2025 at 12:35, 5 months 28 days ago

Immunic Reports Q2 2025 Financial Results with Vidofludimus Calcium Progress

Vidofludimus Calcium Multiple Sclerosis Trials R&D Expenses Biotech Investment Immunic Financial Results
BRIEF

published on 08/07/2025 at 12:35, 5 months 28 days ago

Immunic publie ses résultats financiers du deuxième trimestre 2025 avec les progrès du Vidofludimus Calcium

Essais Sur La Sclérose En Plaques Dépenses De R&D Vidofludimus Calcique Résultats Financiers D'Immunic Investissement Dans Les Biotechnologies
PRESS RELEASE

published on 08/07/2025 at 12:30, 5 months 28 days ago

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports positive Q2 2025 results with focus on clinical progress of vidofludimus calcium for multiple sclerosis treatment

Clinical Trials Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Q2 2025 Results

Accesswire

Published on 02/04/2026 at 18:00, 1 hour 53 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 3 hours 38 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 4 hours 8 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 4 hours 53 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 5 hours 23 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 18:55, 58 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 1 hour 13 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:34, 1 hour 18 minutes ago

E-PANGO: Composition du capital au 31 janvier 2026
Published on 02/04/2026 at 18:14, 1 hour 39 minutes ago

Issue of Equity
Published on 02/04/2026 at 18:05, 1 hour 48 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

Les Echos

Published on 02/04/2026 at 18:04, 1 hour 49 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 1 hour 49 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 2 hours 8 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 2 hours 8 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 2 hours 8 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE